Research Article

Overexpression of Runt-Related Transcription Factor-2 Is Associated with Advanced Tumor Progression and Poor Prognosis in Epithelial Ovarian Cancer

Figure 2

Kaplan-Meier overall (a) and progression-free (b) survival curves for epithelial ovarian cancer patients with high and low RUNX2 expression. Epithelial ovarian cancer patients with high RUNX2 expression had significantly shorter overall ( 𝑃 < 0 . 0 0 1 ) and progression-free ( 𝑃 = 0 . 0 0 2 ) survival than those with low RUNX2 expression did.
456534.fig.002a
(a)
456534.fig.002b
(b)